Crescent Biopharma Inc.

NASDAQ: CBIO · Real-Time Price · USD
13.89
-0.04 (-0.29%)
At close: Aug 15, 2025, 3:59 PM
14.06
1.19%
After-hours: Aug 15, 2025, 07:27 PM EDT

Crescent Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Net Income
17.9M -8.24M -87.93M
Depreciation & Amortization
1.55M 230K 290K
Stock-Based Compensation
831K 1.34M 3.4M
Other Working Capital
n/a -338K -5.39M
Other Non-Cash Items
n/a -21.48M 3.89M
Deferred Income Tax
n/a n/a -3.89M
Change in Working Capital
n/a -4.95M 483K
Operating Cash Flow
-3.64M -33.1M -83.75M
Capital Expenditures
-2.31M n/a -839K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-1.69M n/a n/a
Sales Maturities Of Investments
n/a 57.5M 49.03M
Other Investing Acitivies
-15.88M -2.08M 49.03M
Investing Cash Flow
-19.88M 55.43M 48.19M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a -45.03M n/a
Other Financial Acitivies
1.33M 20K 49.55M
Financial Cash Flow
2.1M -45.01M 49.55M
Net Cash Flow
-21.7M -22.68M 13.99M
Free Cash Flow
-5.96M -33.1M -84.59M